CSPG5 and obesity disorder: For example, in the murine High-Fat diet induced model of obesity, treatment of mice with LNFPIII-NGC alleviated liver hepatosteatosis and improved insulin sensitivity in part, via a macrophage IL-10 dependent mechanism[2].